Category: KneesSyndicate content


Zimmer wins FDA nod for iAssist Knee positioning device

January 18, 2013 by MassDevice staff

Zimmer Holdings says the FDA cleared its iAssist Knee system for helping surgeons accurately position knee implants

Zimmer Holdings

Zimmer (NYSE:ZMH) said it won 510(k) clearance from the FDA for its iAssist Knee personalized guidance system for knee replacements.

Australian DePuy knee implant settlement may cost $68k per patient

December 19, 2012 by MassDevice staff

An Australian judge approves DePuy Orthopaedics' knee implant settlement, granting patients compensation beginning at $32,500 apiece, going as high as $68,200 per patient.

DePuy Orthopaedics logo

An Australian judge approved Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics' lawsuit settlement, in which the company will pay between approximately $32,500 (A$31,000) and $68,200 (A$65,000) to each patient who received a defective knee implant.

U.S. robot surgery market gets a new player with FDA nod for Blue Belt Technologies

December 11, 2012 by MassDevice staff

Blue Belt Technologies enters the robot-assisted surgery market with an FDA win NavioPFS Surgical System for partial knee replacement.

Blue Belt Technologies' NavioPFS system

The U.S. robot-assisted surgery space added a new player this week with FDA clearance for Blue Belt Technologies' NavioPFS orthopedic surgery system.

The Pittsburgh, Pa.-based device maker won clearance with indication for partial knee replacement, a procedure generally performed using manual instruments, the company noted.

ConforMIS launches next-gen iTotal G2 custom knee implants

October 3, 2012 by MassDevice staff

ConforMIS releases its next-generation iTotal G2 knee replacement system, the only patient-specific total knee replacement device left on the market.

ConforMIS logo

Orthopedics devices maker ConforMIS released the latest iteration of its iTotal G2 total knee replacement system, the only such device on the market today, according to the company.

The G2 represents a years' worth of surgeon feedback on the original design, which the FDA cleared in January 2011 and was released to a limited group of surgeons a few months later, according to a press release.

Soaring rates of knee surgery and related complications may point to misuse, researchers say

September 26, 2012 by MassDevice staff

Rates of total knee replacement surgeries have doubled since 1991 and post-procedure complications are on the rise, leading some researchers to wonder whether physicians are playing fast and loose with knee patients.

knee replacement implants xray

A dramatic increase in surgical knee replacement has some researchers concerned that the procedure may be misused.

The ratio of Medicare patients undergoing total knee arthroplasty (TKA) jumped 99.2% between 1991 and 2010, from 31.2 procedures per 10,000 Medicare enrollees to 62.1 procedures per 10,000 enrollees, according to a new study.

"The growth in TKA should prompt consideration of whether too many (or too few) of these procedures are being performed both in aggregate and among key patient subgroups defined by race, sex, or age," the authors wrote.

Arthritis: Zimmer wins knee pain gel patent row against Genzyme

August 7, 2012 by MassDevice staff

A jury decides in Zimmer's favor that the Gel-One arthritis knee pain treatment doesn't infringe on Genzyme's patents.

Lawsuit +3 | The top 3 med-tech stories for August 1, 2012

August 1, 2012 by MassDevice staff

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

If you read nothing else today, make sure you're still in the know with MassDevice +3.